Clinical Trial Update: QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced Hypoglycaemia [NA]

View source ↗

Summary

A completed clinical trial evaluated QT interval abnormalities in patients with type 2 diabetes treated with sulfonylureas and examined the relationship to trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulfonylurea (sulfonylurea)

Snippet

Sponsor: Royal Prince Alfred Hospital, Sydney, Australia | Conditions: Diabetes Related Complications | NA | Status: COMPLETED | Results posted: 2018-02-28